AI-generated summary
The authors randomized 46 patients with Hashimoto's thyroiditis to active or sham low-level laser therapy, twice weekly for three weeks, alongside levothyroxine. They report improved oxidative stress markers and quality of life in both groups, with glutathione and quality of life gains greater in the active group, while thyroid function and autoimmunity did not change.
- Participants
- 46
- Who or what was studied
- Patients diagnosed with Hashimoto's thyroiditis who were also receiving levothyroxine replacement therapy
- Limits stated in the abstract
- The abstract does not report the laser wavelength or dose, and the follow-up was three months after treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oxidative stress, Laser, Sham, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.